Like every business, the Private Equity sector has been buffeted by the COVID-19 crisis.
FalconX is to expand its digital asset trading platform following a new USD17 million VC funding round. Read the full story at Hedgeweek…
Swiss company Creoptix, which received series C funding in September and focuses on next-generation bioanalysis, is supporting Professor Adriano Aguzzi, Professor for Neuropathology at University of Zurich, in developing Covid-19 antibody tests.
A new survey by Intertrust, a global leader in providing tech-enabled fund and corporate solutions, has revealed how fund finance will play a primarily defensive role in helping GPs to combat the impact of Covid-19 while also supporting their investment programmes. During a recent webinar addressing the impact of Covid-19 on
By Jon Mowll, responsible investment analyst at EdenTree Investment Management – The global spread of Covid-19 has increased awareness of systemic issues that predate and have been exacerbated by the pandemic. The virus has raised questions of who and what we – or rather, our economic systems – value, as
Lombard International Group has donated financial aid to Médecins Sans Frontières’ (MSF) Covid-19 Crisis Fund, to support the global health challenges posed by the Covid-19 pandemic and its consequential impacts to vulnerable populations and communities around the world.
By Jeffrey M Bronheim, Daniel H Mathias, James R Mossetto, Cohen & Gresser – The current global Covid-19 pandemic continues to have a major impact on a wide variety of economic activities. For private equity funds, investor uncertainty and the need to preserve cash may drive LPs to question their obligations
It is unlikely that the full extent of mark-to-market valuations will be known until 30 June, when Q2’s financial reports are issued. And while this might cause investors to break out into a cold sweat, the advice being offered by investment consultants is, ‘Don’t make any knee-jerk decisions and keep
Venture capital firm Alumni Ventures Group (AVG), has opened a new fund focused on investing in entrepreneurial companies working to shape and accelerate the world’s recovery from the Covid-19 crisis. The Post-Covid Fund will invest in ventures that either directly or indirectly address the multiple impacts of the virus and that
A majority (83 per cent) of private equity GPs do not expect to make a portfolio exit within the next 12 months in the Covid-19 environment, a new report by Investec reveals.
12 November, 2026 – 5:00 pm
12 November, 2026 – 8:00 am
12 February, 2026 – 8:00 am
12 February, 2026 – 5:00 pm
